Ingevity (NGVT) Capital Expenditures (2015 - 2026)

Ingevity (NGVT) has 12 years of Capital Expenditures data on file, last reported at $10.3 million in Q1 2026.

• On a quarterly basis, Capital Expenditures rose 255.17% year-over-year to $10.3 million in Q1 2026; TTM through Mar 2026 was $2.0 million, a 96.87% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 97.81% from the prior year.
• Capital Expenditures for Q1 2026 stood at $10.3 million, up from -$32.4 million in the prior quarter.
• Over the last five years, Capital Expenditures for NGVT reached as high as $75.4 million in Q4 2024 and fell as low as -$88.4 million in Q4 2022.
• Historically, Capital Expenditures has averaged $10.8 million across 5 years, with a median of $11.9 million in 2025.
• Across the five-year window, Capital Expenditures soared 379.25% in 2023 and plunged 143.16% in 2024, its largest moves.
• Year by year, Capital Expenditures stood at -$88.4 million in 2022, then jumped by 133.03% to $29.2 million in 2023, then surged by 158.22% to $75.4 million in 2024, then sank by 142.97% to -$32.4 million in 2025, then jumped by 131.79% to $10.3 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $10.3 million in Q1 2026, -$32.4 million in Q4 2025, and $11.9 million in Q3 2025.